WAY-100635 has high selectivity for serotonin 5-HT1A versus dopamine D4 receptors

被引：39

作者：

Martel, Jean-Claude

Leduc, Nathalie

Ormiere, Anne-Marie

Faucillon, Valerie

Danty, Nathalie

Culie, Charlene

Cussac, Didier

Newman-Tancredi, Adrian

机构：

[1] Ctr Rech Pierre Fabre, Div Neurobiol 2, F-81106 Castres, France

[2] Ctr Rech Pierre Fabre, Dept Cellular & Mol Biol, F-81106 Castres, France

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2007年 / 574卷 / 01期

关键词：

WAY-100635; serotonin 5-HT1A receptor; dopamine D-4 receptor;

D O I：

10.1016/j.ejphar.2007.07.015

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The serotonin 5-HT1A receptor antagonist WAY-100635 was recently reported to have potent agonist properties at dopamine D-4 receptors (Chernel et al., 2006, Psychopharmacology 188,244-251.). Herein WAY-100635 (pK(i) at human(h) serotonin 5-HT1A receptors=9.5l;pK(i) at dopaminc hD(4.4) receptors=7.42) stimulated [S-35]GTP-gamma S incorporation in membranes of Chinese Hamster Ovary cells expressing dopamine hD4.4 receptors with only moderate potency and modest efficacy (pEC(50) = 6.63; Emax = 19% of dopamine). Moreover, in antagonism experiments, WAY-100635 had a much lower potency at dopamine hD4.4 receptors (pK(B) = 7.09), than at serotonin h5-HT1A receptors (pK(B) = 9.47). These data demonstrate that WAY-100635 has high selectivity for serotonin h5-HT1A versus doparnine hD(4.4) receptors. (C) 2007 Elsevier B.V. All rights reserved.

引用

页码：15 / 19

页数：5

共 50 条

[21] WAY-100635, an antagonist of 5-HT1A receptor, causes malformations of the CNS in ascidian embryos
Pennati, R
Groppelli, S
Sotgia, C
Zega, G
Pestarino, M
De Bernardi, F
DEVELOPMENT GENES AND EVOLUTION, 2003, 213 (04) : 187 - 192
[22] The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors
Cosi, C
Koek, W
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (01) : 9 - 15
[23] Analogues of WAY 100635 as radiotracers for in vivo imaging of 5-HT1A receptors
Wilson, AA
Garcia, A
Li, J
DaSilva, JN
Houle, S
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1999, 42 (07): : 611 - 620
[24] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors
A. Newman-Tancredi
D. Cussac
V. Audinot
M. J. Millan
Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 447 - 453
[25] Verbal memory and 5-HT1A receptors in healthy volunteers - A PET study with [carbonyl-11C]WAY-100635
Penttila, Jani
Hirvonen, Jussi
Tuominen, Lauri
Lumme, Ville
Ilonen, Tuula
Nagren, Kjell
Hietala, Jarmo
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (03) : 570 - 577
[26] PET-characterization of [carbonyl-C-11]WAY-100635 binding to 5-HT1A receptors in the primate brain
Farde, L
Ginovart, N
Ito, H
Lundkvist, C
Pike, VW
McCarron, JA
Halldin, C
PSYCHOPHARMACOLOGY, 1997, 133 (02) : 196 - 202
[27] Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635
Tauscher, J
Kapur, S
Verhoeff, NPLG
Hussey, DF
Daskalakis, ZJ
Tauscher-Wisniewski, S
Wilson, AA
Houle, S
Kasper, S
Zipursky, RB
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (06) : 514 - 520
[28] PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain
L. Farde
Nathalie Ginovart
Hiroshi Ito
Camilla Lundkvist
Victor W. Pike
Julie A. McCarron
Christer Halldin
Psychopharmacology, 1997, 133 : 196 - 202
[29] Short and efficient syntheses of analogues of WAY-100635:: New and potent 5-HT1A receptor antagonists
Marchais, S
Nowicki, B
Wikström, H
Brennum, LT
Halldin, C
Pike, VW
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) : 695 - 702
[30] [carbonyl-C-11]WAY-100635 - A radioligand for the exquisite delineation of 5-HT1A receptors in human brain with PET.
Pike, VW
McCarron, JA
Lammertsma, AA
Osman, S
Hume, SP
Sargent, PA
Grasby, PM
Fletcher, A
Cliffe, IA
Bench, CJ
JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (10) : 1830 - 1830

← 1 2 3 4 5 →